Back
Cytokinetics Stock Predictions
Buy
55
CYTK
Cytokinetics
Last Price:
53.96
Seasonality Move:
7.55%
7 Day Trial
ALL ACCESS PASS
$
7
Cytokinetics Stock Forecast
- Over the next 52 weeks, Cytokinetics has on average historically risen by 8.7% based on the past 20 years of stock performance.
- Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
-
Is Cytokinetics Stock Undervalued?
The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Cytokinetics Stock Go Up Next Year?
- Over the next 52 weeks, Cytokinetics has on average historically risen by 8.7% based on the past 20 years of stock performance.
Cytokinetics Stock Rating
Buy
55
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics overpriced?
- Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
Cytokinetics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
110.25
52-Week Low:
25.98
Prediction Charts
Market Cap:
5.65B
Price in USD:
53.93
Volume:
1.18M
Beta:
1.45
Technical Analysis
SMA50:
60.85
SMA100:
67.11
SMA200:
55.30
52-Wk Change:
54.04%
Stock Predictions
-
Is Cytokinetics stock public?
Yes, Cytokinetics is a publicly traded company. -
What is the Cytokinetics stock quote today?
The Cytokinetics stock price is 53.93 USD today. -
How to buy Cytokinetics stock online?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-28 | 48.68 | 48.24 | 49.32 | 46.25 |
May-29 | 48.08 | 47.86 | 49.25 | 46.70 |
May-30 | 48.33 | 49.12 | 49.82 | 47.18 |
May-31 | 49.25 | 48.51 | 49.36 | 48.03 |
Jun-3 | 48.64 | 49.87 | 50.34 | 48.11 |
Jun-4 | 49.16 | 48.41 | 49.38 | 47.82 |
Jun-5 | 48.68 | 54.58 | 55.00 | 47.02 |
Jun-6 | 54.25 | 52.28 | 54.75 | 52.00 |
Jun-7 | 52.10 | 52.79 | 52.94 | 50.87 |
Jun-10 | 52.07 | 54.16 | 54.45 | 51.51 |
Jun-11 | 53.52 | 53.29 | 54.04 | 52.56 |
Jun-12 | 54.50 | 54.03 | 54.83 | 53.56 |
Jun-13 | 54.02 | 52.73 | 54.41 | 52.67 |
Jun-14 | 52.23 | 53.93 | 54.35 | 51.87 |
Cytokinetics Earnings
Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics Forecast Revenue Growth
Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.